Delisting risk
Oncolytics Biotech
Develops pelareorep, a double-stranded RNA immunotherapy for gastrointestinal tumors.
$0.8526
After-hours close−0.01 (−0.79%)
At close$0.8594(+1.11%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.07 | — | — |
| Aug 2026 | −$0.05 | −$0.08 | −48.7% |
| May 2026 | −$0.05 | −$0.08 | −60.0% |
| Mar 2026 | −$0.06 | −$0.08 | −33.3% |
| Nov 2025 | −$0.12 | −$0.10 | +16.7% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Aug 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 11, 2026 | −$0.07 | — | — | — | — | — |
| Aug 12, 2026 | −$0.05 | −$0.08 | −48.7% | — | — | — |
| May 14, 2026 | −$0.05 | −$0.08 | −60.0% | — | — | — |
| Mar 30, 2026 | −$0.06 | −$0.08 | −33.3% | — | — | — |
| Nov 12, 2025 | −$0.12 | −$0.10 | +16.7% | — | — | — |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | ||||||
| Aug 8, 2025 | ||||||
| May 14, 2025 | ||||||
| Mar 7, 2025 | ||||||
| Nov 12, 2024 | ||||||
| Aug 1, 2024 | ||||||
| May 9, 2024 | ||||||
| Mar 7, 2024 | ||||||
| Nov 3, 2023 | ||||||
| Aug 14, 2023 | ||||||
| May 5, 2023 | ||||||
| Mar 3, 2023 | ||||||
| Nov 7, 2022 | ||||||
| Aug 11, 2022 | ||||||
| May 5, 2022 | ||||||
| Mar 3, 2022 | ||||||
| Nov 5, 2021 | ||||||
| Aug 6, 2021 | ||||||
| May 7, 2021 | ||||||
| Mar 5, 2021 | ||||||
| Nov 11, 2020 | ||||||
| Aug 4, 2020 | ||||||
| May 8, 2020 | ||||||
| Mar 5, 2020 | ||||||
| Nov 12, 2019 | ||||||
| Aug 13, 2019 | ||||||
| May 2, 2019 | ||||||
| Mar 8, 2019 | ||||||
| Nov 12, 2018 | ||||||
| Aug 3, 2018 | ||||||
| May 11, 2018 | ||||||
| Mar 9, 2018 | ||||||
| Nov 8, 2017 | ||||||
| Aug 3, 2017 | ||||||
| May 5, 2017 | ||||||
| Mar 10, 2017 | ||||||
| Nov 3, 2016 | ||||||
| Aug 4, 2016 | ||||||
| May 6, 2016 | ||||||
| Mar 11, 2016 | ||||||
| Nov 5, 2015 | ||||||
| Aug 6, 2015 | ||||||